Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

RNTXRNTX
Showing 8 of 14 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in REIN THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 344,690 shares of RNTX (REIN THERAPEUTICS INC), worth $448,185 as of 2026-Q1. The position was increased (+21.1% shares).

Current Value

$448,185

Current Shares

344,690

Total Value Change

-$23,952

Total Shares Change

+174,243

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
344,690
+21.1%
$448,1850.0%$1.15
20
2025-Q4
Increased
284,555
+15.1%
$330,1590.0%$1.07
18
2025-Q3
Increased
247,311
+0.8%
$283,2490.0%$1.15
16
2025-Q2
Decreased
245,455
-0.3%
$343,7250.0%$1.47
0
2025-Q1
Increased
246,096
+1.9%
$435,7240.0%$1.70
17
2024-Q4
Increased
241,437
+5.1%
$555,4800.0%$2.32
17
2024-Q3
Increased
229,817
+34.8%
$813,7700.0%$3.65
32
2024-Q2
Increased
170,447
+144.3%
$472,1370.0%$2.77
26

Other major holders of RNTX: Alyeska Investment Group, L.P., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used